Attached files
| file | filename |
|---|---|
| S-1/A - MedClean Technologies, Inc. | v178391_s1a.htm |
| EX-23.1 - MedClean Technologies, Inc. | v178391_ex23-1.htm |
| EX-10.16 - MedClean Technologies, Inc. | v178391_ex10-16.htm |
March 26,
2010
MedClean
Technologies, Inc.
3
Trowbridge Drive
Bethel,
Connecticut 06801
Gentlemen:
You have
requested our opinion, as counsel for MedClean Technologies, Inc., a Delaware
corporation (the “Company”), in connection with Amendment No.2 to the Form S-1
registration statement, under the Securities Act of 1933 (the “Act”), filed by
the Company with the Commission.
The
Registration Statement relates to an offering of 172,500,000 shares of the
Company’s common stock.
We have
examined such records and documents and made such examination of laws as we have
deemed relevant in connection with this opinion. It is our opinion that the
shares of common stock to be sold by the selling shareholders have or will have
been duly authorized and are or will be legally issued, fully paid and
non-assessable.
No
opinion is expressed herein as to any laws other than the state of Delaware of
the United States. This opinion opines upon Delaware law including the statutory
provisions, all applicable provisions of the Delaware Constitution and reported
judicial decisions interpreting those laws.
We hereby
consent to the filing of this opinion as an exhibit to the Registration
Statement, the use of our name under the caption “Legal Matters” and to the
reference to our firm under the caption “Experts” in the Registration Statement.
In so doing, we do not admit that we are in the category of persons whose
consent is required under Section 7 of the Act and the rules and regulations of
the Commission promulgated thereunder.
Very
truly yours,
ANSLOW
& JACLIN, LLP
|
By:
/s/ Anslow & Jaclin,
LLP
|
|
195 Route
9 South, Suite 204, Manalapan, New Jersey 07726
Tel:
(732) 409-1212 Fax: (732) 577-1188